13.60

2.64% 0.35

After Hours: 13.57 -0.03 -0.22%

Benitec Biopharma Inc (BNTC)

Overview News Price History Financials Discussions Forecast Stock Split

Benitec Biopharma Inc stock is traded at $13.60, with a volume of 175.90K. It is up +2.64% in the last 24 hours and up +15.74% over the past month. Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Previous Close:

$13.25

Open:

$13.16

24h Volume:

175.90K

Relative Volume:

1.16

Market Cap:

$467.22M

Revenue:

$7,000

Net Income/Loss:

$-38.96M

P/E Ratio:

-14.63

EPS:

-0.9296

Net Cash Flow:

$-18.34M

1W Performance:

+22.97%

1M Performance:

+15.74%

6M Performance:

-14.47%

1Y Performance:

-0.58%

1-Day Range:

$12.33

$13.97

1-Week Range:

$10.56

$13.97

52-Week Range:

$9.85

$17.15

Benitec Biopharma Inc Stock (BNTC) Company Profile

Name

Benitec Biopharma Inc

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

(510) 780-0819

Address

3940 TRUST WAY, HAYWARD, CA

Employee

Twitter

@BenitecLtd

Next Earnings Date

2024-11-11

Latest SEC Filings

BNTC's Discussions on Twitter

Compare BNTC vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BNTC Benitec Biopharma Inc	13.60	455.19M	7,000	-38.96M	-18.34M	-0.9296
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-07-25	Initiated	TD Cowen	Buy
Dec-16-24	Initiated	H.C. Wainwright	Buy
Dec-13-24	Initiated	Robert W. Baird	Outperform
Oct-16-24	Initiated	Oppenheimer	Outperform
Sep-12-24	Initiated	Guggenheim	Buy
Jul-22-24	Initiated	Leerink Partners	Outperform
Jun-13-24	Initiated	Piper Sandler	Overweight
Oct-05-20	Downgrade	Ladenburg Thalmann	Buy → Neutral
Apr-20-20	Initiated	Ladenburg Thalmann	Buy
Feb-26-16	Downgrade	Maxim Group	Buy → Hold
Dec-31-15	Reiterated	Maxim Group	Buy
Sep-16-15	Reiterated	Maxim Group	Buy

View All

Benitec Biopharma Inc Stock (BNTC) Latest News

Apr 14, 2026

Price-Driven Insight from (BNTC) for Rule-Based Strategy - Stock Traders Daily

Apr 14, 2026

Apr 13, 2026

Macro Review: How liquid is Benitec Biopharma Inc stock2026 Key Highlights & Daily Momentum Trading Reports - baoquankhu1.vn

Apr 13, 2026

Quarterly Earnings: Does Benitec Biopharma Inc meet Warren Buffetts criteria2026 Earnings Surprises & Advanced Technical Signal Analysis - baoquankhu1.vn

Apr 13, 2026

Apr 11, 2026

Is Benitec Biopharma Inc part of any major index2026 Geopolitical Influence & High Return Trade Opportunity Guides - baoquankhu1.vn

Apr 11, 2026

Apr 09, 2026

Entry Recap: What is the Moat Score of Benitec Biopharma IncEarnings Growth Report & Technical Confirmation Alerts - baoquankhu1.vn

Apr 09, 2026

Apr 03, 2026

(BNTC) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Apr 03, 2026

Apr 02, 2026

Ideas Watch: How liquid is Benitec Biopharma Inc stockPortfolio Profit Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Apr 02, 2026

Mar 30, 2026

Aug Sectors: Can Benitec Biopharma Inc maintain its current growth rate2026 Technicals & Weekly High Conviction Ideas - baoquankhu1.vn

Mar 30, 2026

Mar 29, 2026

Market Wrap: Is Benitec Biopharma Inc stock a buy or sellQuarterly Market Summary & AI Enhanced Trading Alerts - baoquankhu1.vn

Mar 29, 2026

Mar 25, 2026

Benitec Biopharma (NASDAQ:BNTC) Shares Pass Below Fifty Day Moving AverageHere's What Happened - MarketBeat

Mar 25, 2026

Benitec Biopharma (NASDAQ:BNTC) Shares Pass Below Fifty Day Moving Average – Here’s What Happened - Defense World

Mar 25, 2026

Benitec Biopharma Limited (NASDAQ:BNTC) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Mar 25, 2026

Mar 23, 2026

(BNTC) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Mar 23, 2026

Mar 21, 2026

Market Moves: Is Benitec Biopharma Inc forming a double bottom2026 Closing Moves & Verified Short-Term Plans - baoquankhu1.vn

Mar 21, 2026

Mar 20, 2026

Benitec Biopharma (NASDAQ:BNTC) Stock Price Crosses Above 50 Day Moving AverageWhat's Next? - MarketBeat

Mar 17, 2026

Mar 16, 2026

Risk Recap: What is the dividend yield of Benitec Biopharma Inc2026 Setups & Low Drawdown Trading Strategies - baoquankhu1.vn

Mar 16, 2026

Mar 14, 2026

Portfolio Recap: Is Benitec Biopharma Inc stock a good dividend stockDollar Strength & High Accuracy Swing Trade Signals - baoquankhu1.vn

Mar 14, 2026

Mar 13, 2026

Jerel A. Banks, MD, PhD, on Evaluating Gene Therapy BB-301 for OPMD-Related Dysphagia - CGTLive®

Mar 13, 2026

Surprises Report: Can Benitec Biopharma Inc maintain its current growth rate2026 Fundamental Recap & Intraday High Probability Alerts - baoquankhu1.vn

Mar 13, 2026

Mar 12, 2026

(BNTC) Risk Channels and Responsive Allocation - Stock Traders Daily

Mar 12, 2026

Mar 10, 2026

Benitec Biopharma to Host Industry Forum Breakfast Event at the 2026 Muscular Dystrophy Association Clinical and Scientific Conference on March 10, 2026, Highlighting Continued Progress for BB-301, the Only Clinical-Stage Therapeutic in Development for - The Manila Times

Mar 10, 2026

Benitec Biopharma to Host Industry Forum Breakfast Event at - GlobeNewswire

Mar 10, 2026

Benitec Biopharma (NASDAQ:BNTC) Receives Buy Rating from HC Wainwright - Defense World

Mar 10, 2026

Cowen Reiterates Buy on Benitec Biopharma (BNTC) March 2026 - Meyka

Mar 10, 2026